Formyco
GER:FYB · DE000A1EWVY8
BiotechnologySmall
360
42
Medium confidence — indicative
Value40
Quality55
Growth51
Safety—
Sentiment45
Value Creation3/20not creating value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
Formyco doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.
Based on 3/5 components.
Profile
CountryGermany
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeXTRA
Founded2012
Employees164
Websiteformycon.com
ISINDE000A1EWVY8
Last UpdateApr 2, 2026
Indices
Themes
RheumatologyDermatologyChronic DiseasesOncologyImmunologyOphthalmologyInflammationBiopharma
Description
Analysis
Middle-of-the-road
Formycon AG is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100